EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

De‐Novo Design of pre‐miR‐21 Maturation Inhibitors: Synthesis and Activity Assessment

Iryna Shcheholeva, Daniel Fernández-Remacha, Roger Estrada-Tejedor, Maria Duca, Véronique Michelet

Chemistry – A European Journal · 2023

DOI: 10.1002/chem.202300825 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, 2023. Verfasst von Iryna Shcheholeva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Université Côte d'Azur, Institut de Chimie de Nice (ICN), CNRS, Parc Valrose, 06100, Nice, France. Hauptthemen laut MEDLINE: Drug Design, MicroRNAs. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: UCAJEDI Investments in the Future project Region PACA and BoostUrCareer project European Union's Horizon 2020.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting RNA with small molecules is a major challenge of current medicinal chemistry, and the identification and design of original scaffolds able to selectively interact with an RNA target remains difficult. Various approaches have been developed based on classical medicinal chemistry strategies (fragment‐based drug design, dynamic combinatorial chemistry, HTS or DNA‐encoded libraries) as well as on advanced structural biology and biochemistry methodologies (such as X‐ray, cryo‐EM, NMR, or SHAPE). Here, we report the de novo design, synthesis, and biological evaluation of RNA ligands by using a straightforward and sustainable chemistry combined with molecular docking and biochemical and biophysical studies that allowed us to identify a novel pharmacophore for RNA binding. Specifically, we focused on targeting the biogenesis of microRNA‐21, the well‐known oncogene. This led us not only to promising inhibitors but also to a better understanding of the interactions between the small‐molecule compounds and the RNA target paving the way for the rational design of efficient inhibitors with potential anticancer activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DesignMicroRNAsMolecular Docking SimulationCombinatorial Chemistry TechniquesLigands

Stichwörter der Autor:innen

RNAbinding mechanismsdrug discoveryinhibitorsoncogenes

Substanzen

MicroRNAsLigands

Autor:innen und Institutionen

  • Université Côte d'Azur, Institut de Chimie de Nice (ICN), CNRS, Parc Valrose, 06100, Nice, France.
  • IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, 08017, Barcelona, Spain.

Förderung

  • UCAJEDI Investments in the Future project Region PACA and BoostUrCareer project European Union's Horizon 2020

Zitieren

APA

Shcheholeva, I., Fernández-Remacha, D., Estrada-Tejedor, R., Duca, M., & Michelet, V. (2023). De‐Novo Design of pre‐miR‐21 Maturation Inhibitors: Synthesis and Activity Assessment. Chemistry – A European Journal. https://doi.org/10.1002/chem.202300825

Vancouver

Shcheholeva I, Fernández-Remacha D, Estrada-Tejedor R, Duca M, Michelet V. De‐Novo Design of pre‐miR‐21 Maturation Inhibitors: Synthesis and Activity Assessment. Chemistry – A European Journal. 2023. doi:10.1002/chem.202300825

BibTeX
@article{Shcheholeva2023,
  author = {Shcheholeva, Iryna and Fernández-Remacha, Daniel and Estrada-Tejedor, Roger and Duca, Maria and Michelet, Véronique},
  title = {De‐Novo Design of pre‐miR‐21 Maturation Inhibitors: Synthesis and Activity Assessment},
  journal = {Chemistry – A European Journal},
  year = {2023},
  doi = {10.1002/chem.202300825}
}
Kostenlos starten →